Further studies on a larger number of subjects are needed to assess whether longer-term DPP-4 inhibitor treatment is safe and has beneficial effect on cardiac function in T2DM patients with or without overt heart failure. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.